Jonathan Kerr

2019-06-30T17:29:54Z

Dr enlander:update

[[File:Jonathan Kerr.png|200px|thumb|right|Source: Invest in ME]]
'''Jonathan Ricardo Kerr''', BSc, MBBCh, MD, PhD, FRCPath, is a British researcher who became interested in [[ME/CFS]] after studying the consequences of [[Parvovirus B19]] infection and finding that some of those infected went on to develop [[CFS]]. Formerly of St. George’s University of London,<ref>http://www.investinme.eu/IIMEC1.shtml#presenters</ref> he was working as an Associate professor in the School of Medicine and Health Sciences at Universidad del Rosario, Bogotá, Colombia.<ref>http://www.urosario.edu.co/Profesores/Listado-de-profesores/K/Kerr-Jonathan-Ricardo/</ref> He has returned to the UK in 2018

==Notable studies==
*1997, [[Parvovirus B19]] and Chronic Fatigue Syndrome<ref>Jonathan R. Kerr, Ann-Marie Barrett, Martin D. Curran, Wilhelmina M. H. Behan, Derek Middleton, and [[Peter Behan|P.O. Behan]]. (1997). Parvovirus B19 and Chronic Fatigue Syndrome. ''Journal of Chronic Fatigue Syndrome,'' Vol. 3, Iss. 3, pp 101-107. doi:10.1300/J092v03n03_07</ref> [https://www.tandfonline.com/doi/abs/10.1300/J092v03n03_07 (Abstract)]
*2005, [[Gene expression]] in peripheral [[blood]] mononuclear cells from patients with chronic fatigue syndrome<ref>Kaushik, N., Fear, D., Richards, S. C. M., McDermott, C. R., Nuwaysir, E. F., Kellam, P., … Kerr, J. R. (2005). Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. Journal of Clinical Pathology, 58(8), 826–832. http://doi.org/10.1136/jcp.2005.025718</ref> [http://jcp.bmj.com/content/67/12/1078 (Full Text)]
*2005, Association of chronic fatigue syndrome with human leucocyte antigen class II alleles<ref>Smith, J., Fritz, E. L., Kerr, J. R., Cleare, A. J., Wessely, S., & Mattey, D. L. (2005). Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. Journal of Clinical Pathology, 58(8), 860–863. http://doi.org/10.1136/jcp.2004.022681</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770867/ (Full Text)]
*2007, Review - Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments<ref>J R Kerr, P Christian, A Hodgetts, P R Langford, L D Devanur, R Petty, B Burke, L I Sinclair, S C M Richards, J Montgomery, C R McDermott, T J Harrison, P Kellam, D J Nutt, S T Holgate, and the Collaborative Clinical Study Group (2007) Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments, JOURNAL OF CLINICAL PATHOLOGY, Vol: 60, Pages: 113-116, DOI: 10.1136/jcp.2006.042374</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860619/ (Full Text)]
*2008, Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref name="Kerr, 2008" /> [https://academic.oup.com/jid/article/197/8/1171/903299 (Full Text)]
*2009, Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis<ref>Zhang L, Gough J, Christmas D, et al., Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Clinical Pathology 2010;63:156-164. DOI: 10.1136/jcp.2009.072561</ref> [http://jcp.bmj.com/content/63/2/156 (Full Text)]
*2008, Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis<ref name="Kerr, 2008" /> [https://academic.oup.com/jid/article/197/8/1171/903299 (Full Text)]
*2010, Antibody to [[parvovirus B19]] nonstructural protein is associated with chronic [[arthralgia]] in patients with chronic fatigue syndrome/myalgic encephalomyelitis<ref>Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, Komaroff AL, Chia JK. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol. 2010 Apr;91(Pt 4):893-7. doi: 10.1099/vir.0.017590-0</ref> [http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.017590-0#tab2 (Full Text)]
*2014, Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)<ref name="Shimosako, 2014" /> [http://jcp.bmj.com/content/67/12/1078 (Abstract)]
*2016, [http://repository.urosario.edu.co/handle/10336/12243 Prevalencia de síntomas de fatiga crónica / encefalomielitis miálgica (SFC/EM) y su relación con factores ocupacionales en trabajadores en una empresa de vigilancia en Bogotá, Colombia] (Jonathan Kerr) Note: This study did not use [[PEM]] as a inclusionary symptom nor did it use any [[Definitions of ME and CFS]] including the most symptom liberal of valid definitions, [[SEID]]. The only entry criteria noted were fatigue and muscle pain which seem to be the broadest and loose of symptom definitions [[Reeves criteria]] and [[Oxford criteria]].
*2016, MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential [[Diagnostic biomarker|Diagnostic Biomarkers]] in [[Natural killer cell|Natural Killer (NK) Cells]] of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)<ref>{{Citation
| last1 = Petty
| first1 = Robert D.
| authorlink1 = Robert Petty
| last2 = McCarthy
| first2 = Nail E.
| authorlink2 = Neil McCarthy
| last3 = Le Dieu
| first3 = Rifca
| authorlink3 = Rifca Le Dieu
| last4 = Kerr
| first4 = Jonathan R.
| authorlink4 = Jonathan Kerr
| display-authors =
| title = MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)
| journal = PLOS One
| year = 2016
| pmid = 26967895
| doi = 10.1371/journal.pone.0150904
}}</ref> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150904 (Full Text)]
*2019, Review article - [[Epstein-Barr virus]] induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis<ref>{{Cite journal|last=Kerr|first=Jonathan R.|author-link=Jonathan Kerr|author-link2=|author-link3=|author-link4=|author-link5=|date=Feb 2019|title=Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis|url=https://www.frontiersin.org/articles/10.3389/fped.2019.00059/abstract|journal=Frontiers in Pediatrics|volume=|issue=|pages=|doi=10.3389/fped.2019.00059|quote=|via=}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2019.00059/abstract (Abstract)]

==Talks & interviews==
*2014, [http://phoenixrising.me/archives/25982 Dr. Kerr, I presume?]
*2015, [http://www.drcourtneycraig.com/blog/2015/10/15/spoonie-radio-ep-14-dr-jonathan-kerr- Spoonie Radio - episode 14 - Jonathan Kerr]

==Invest in ME International ME Conference==
*2006, [http://www.investinme.eu/IIMEC1.shtml#agenda Speaker at the 1st] [[Invest in ME International ME Conference]] on ''Viral and Human Gene Expression, development of diagnostic test, news of clinical trials''<ref>http://www.investinme.eu/IIMEC1.shtml#agenda</ref> [http://www.investinme.eu/IIMEC1.shtml#dvd DVD available]
*2007, [http://www.investinme.eu/IIMEC2.shtml#agendaSpeaker at the 2nd] [[Invest in ME International ME Conference]] on ''Case Study - Biomedical research (A view of a biomedical research team, how it is funded, what it needs, how it could be improved, what the future research would look like)''<ref>http://www.investinme.eu/IIMEC2.shtml#agenda</ref> [http://www.investinme.eu/IIMEC2.shtml#dvd DVD available]
*2008, [http://www.investinme.eu/IIMEC3.shtml#agenda Speaker at the 3rd] [[Invest in ME International ME Conference]] on ''Gene Expression in ME/CFS: a means of Subtyping''<ref>http://www.investinme.eu/IIMEC3.shtml#agenda</ref> [http://www.investinme.eu/IIMEC3.shtml#dvd DVD available]
*2009, [http://www.investinme.eu/IIMEC4.shtml#agenda Speaker at the 4th] [[Invest in ME International ME Conference]] on ''Severely-affected Sub Groups of ME/CFS''<ref>http://www.investinme.eu/IIMEC4.shtml#agenda</ref> [http://www.investinme.eu/IIMEC4.shtml#dvd DVD available]
*2010, [http://www.investinme.eu/IIMEC5.shtml#agenda Speaker at the 5th] [[Invest in ME International ME Conference]] on ''Study of SNPs to determine subtype status in CFS patients''<ref>http://www.investinme.eu/IIMEC5.shtml#agenda</ref> [http://www.investinme.eu/IIMEC5.shtml#dvd DVD available]

==Online presence==
*[http://www.investinme.org/JonathanKerr.htm Invest in ME - Jonathan Kerr]
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Kerr%20JR%5BAuthor%5D&cauthor=true&cauthor_uid=26967895 PubMed - Jonathan Kerr]

==Learn more==
*[http://www.urosario.edu.co/Profesores/Listado-de-profesores/K/Kerr-Jonathan-Ricardo/ Jonathan Kerr]

==See also==

==References==
<references>
<ref name="Kerr, 2008">{{Citation
| last1 = Kerr | first1 = Jonathan R | authorlink1 = Jonathan Kerr
| last2 = Petty | first2 = Robert | authorlink2 =
| last3 = Burke | first3 = Beverley | authorlink3 =
| last4 = Gough | first4 = John | authorlink4 =
| last5 = Fear | first5 = David | authorlink5 =
| last6 = Sinclair | first6 = Lindsey I | authorlink6 =
| last7 = Mattey | first7 = Derek L | authorlink7 =
| last8 = Richards | first8 = Selwyn C | authorlink8 =
| last9 = Montgomery | first9 = Jane | authorlink9 =
| last10 = Baldwin | first10 = Don A | authorlink10 =
| last11 = Kellam | first11 = Paul | authorlink11 =
| last12 = Harrison | first12 = Tim J | authorlink12 =
| last13 = Griffin | first13 = George E | authorlink13 =
| last14 = Main | first14 = Janice | authorlink14 =
| last15 = Enlander | first15 = Derek | authorlink15 = Derek Enlander
| last16 = Nutt | first16 = David J | authorlink16 =
| last17 = Holgate | first17 = Stephen T | authorlink17 = Stephen Holgate
| title = Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
| journal = The Journal of Infectious Diseases | volume = 197 | issue = 8 | page = 1171–1184
| date = 15 April 2008
| pmid =
| doi = 10.1086/533453
}}
</ref>
<ref name="Shimosako, 2014">{{Citation
| last1 = Shimosako | first1 = Nana | authorlink1 =
| last2 = Kerr | first2 = Jonathan R. | authorlink2 = Jonathan Kerr
| title = Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
| journal = Journal of Clinical Pathology | volume = 67 | issue = 12 | page =
| date = 2014
| pmid =
| doi = 10.1136/jclinpath-2014-202597
}}
</ref>
</references>
[[Category:Researchers]]
[[Category:UK researchers]]

MEpedia - User contributions [en]

Jonathan Kerr